Largest Biotech to IPO Leaves Analysts Bewildered at Valuation

(Bloomberg) — Moderna Inc.’s potentially historic stock-market debut on Friday is already attracting skeptics on Wall Street. The biotech firm has been hoping to raise as much as $600 million …